Tate & Lyle PLC
Tate & Lyle announces major increase in sucralose capacity to reflect growing
demand
Tate & Lyle announced today a significant expansion of its sucralose plant in
McIntosh, Alabama at a total capital cost of £16 million (US $30 million). The
expansion will use the existing patented manufacturing process and will be
completed by January 2006.
The project will be funded from existing resources and is expected to cover the
Group's cost of capital in the second year of operation.
Iain Ferguson, Chief Executive of Tate & Lyle, said:
'We have been delighted by the strong customer-led demand for
SPLENDA(R)Sucralose since we completed the sucralose realignment in April this
year. This growth is across all categories and includes the introduction of new
mid-calorie carbonated beverages containing sucralose.'
Tate & Lyle announced the realignment of its sucralose agreements with
McNeil Nutritionals (a division of McNeil-PPC, Inc., a Johnson &
Johnson company) on 19 February 2004 with the transaction completing
in April 2004. As a result, Tate & Lyle became the sole manufacturer
and responsible for the world-wide ingredient sales of SPLENDA(R)
Sucralose to food and beverage manufacturers. McNeil Nutritionals is
responsible for the world-wide SPLENDA(R)Brand retail and foodservice
business. Tate & Lyle supplies McNeil Nutritionals sucralose on an
exclusive basis.
CONTACTS
Mark Robinson, Head of Investor Relations
Tel: 020 7626 6525 or Mobile: 07793 515861 investorrelations@tateandlyle.com
Chris Fox, Director of Corporate Relations (Press)
Tel: 020 7626 6525 or Mobile: 07801 808553
Tate & Lyle is a world leader in ingredients. Its core competence is to take
corn, wheat or sugar, and add value to these raw materials through technology.
As a result of continuous innovation it offers an ever-wider product portfolio
of versatile and functional ingredients. These products include Cereal
Sweeteners, Starches, Sugars and Citric Acid. Tate & Lyle products have wide
applications in the food, beverage, pharmaceutical, cosmetic, paper, packaging
and building industries. With headquarters in London, Tate & Lyle operates more
than 41 plants and 20 additional production facilities in 28 countries, almost
all in Europe and the Americas. It employs 6,700 people in its subsidiaries with
a further 4,800 employed in joint ventures. Sales in the year to 31 March 2004
totalled £3,167 million. More details are available on this website
www.tateandlyle.com.
SPLENDA(R) is a trademark of McNeil-PPC, Inc.
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.